---
title: "Research Group Profile"
subtitle: "Pathogenomic and Cellular Mycobacteria Research Group"
format: html
date: last-modified
---

## Group Information

- **Group Name:** Pathogenomic and Cellular Mycobacteria
- **Research Focus:** Investigation of mycobacterial pathogenomics, cellular mechanisms of infection, and host-pathogen interactions, with a strong emphasis on *Mycobacterium tuberculosis*.

## Team Members

### Coordinator

- **Name:** Andriansjah, S.Si, M.Biomed, PhD
- **Title/Credentials:** Doctor, Master in Biomedical Sciences, PhD
- **Email:** andriansjah@ui.ac.id
- **Phone:** +62 21 316 0491

### Members

1. **Dra. Ariyani Kiranasari, M.Biomed**
   - Title/Credentials: Master in Biomedical Sciences
   - Specialization: Biomedical Microbiology and Tuberculosis Drug Resistance
   - Email: ariyani.kiranasari@ui.ac.id

2. **dr. Ardiana Kusumaningrum, Sp.MK (K)**
   - Title/Credentials: Doctor, Clinical Microbiology Specialist (Consultant)
   - Specialization: Clinical Microbiology, Mycobacteriology, and Infectious Disease Diagnostics
   - Email: ardiana.kusumaningrum@ui.ac.id

3. **Prof. dr. Amin Soebandrio W. Kusumo, PhD, Sp.MK (K)**
   - Title/Credentials: Professor, Doctor, PhD, Clinical Microbiology Specialist (Consultant)
   - Specialization: Clinical Microbiology, Molecular Biology, and Emerging Infectious Diseases
   - Email: amin.soebandrio@ui.ac.id

## Research Areas

- Mycobacterial genomics and molecular epidemiology
- Cellular pathogenesis and host immune response to TB
- Tuberculosis drug resistance (MDR/XDR-TB) mechanisms
- Vaccine development and efficacy biomarkers (e.g., MGIA)
- Non-tuberculous mycobacteria (NTM) characterization

## Current Projects

1. **Mycobacterial Growth Inhibition Assay (MGIA) as a Vaccine Efficacy Biomarker**
   - Duration: 2023 - 2025
   - Funding: Universitas Indonesia / National Research Grant
   - Brief description: Validation of MGIA to evaluate the biological activity and protective efficacy of novel tuberculosis vaccine candidates (e.g., pcDNA3.1-rpfD).

2. **Genomic Analysis of Pyrazinamide Resistance in *M. tuberculosis***
   - Duration: 2023 - 2024
   - Funding: Domestic Research Grant
   - Brief description: Whole-genome sequencing analysis of *pncA*, *rpsA*, and *panD* genes to characterize resistance mechanisms in Indonesian *M. tuberculosis* isolates.

3. **TB Lineage Distribution and Drug Resistance Profiling**
   - Duration: 2023 - Present
   - Funding: International Collaboration / Faculty Grant
   - Brief description: Study determining the association between *M. tuberculosis* lineages (using WGS) and phenotypic resistance to new anti-TB drugs like bedaquiline and linezolid.

## Recent Publications

- Rukmana, A., Nurfadillah, M., Gozali, C., & Kiranasari, A. (2024). **Genome sequencing analysis of the *pncA*, *rpsA* and *panD* genes responsible for pyrazinamide resistance of *Mycobacterium tuberculosis* from Indonesian isolates.** *Tropical Medicine and International Health*, 29(11), 964-970.

- Andriansjah, et al. (2024). **Latent Tuberculosis: Interaction of *Mycobacterium tuberculosis* with Macrophages.** *EKSAKTA: Berkala Ilmiah Bidang MIPA*, 25(1), 69-80.

- Nurfadillah, M., ... Andriansjah, et al. (2024). **Mycobacterium tuberculosis Lineage Distribution Using Whole Genome Sequencing and Bedaquiline, Clofazimine, and Linezolid Phenotypic Profile Resistance Among Rifampicin-Resistant Isolates From West Java, Indonesia.** *Pharmaceutical Sciences and Research*, 11(1).

- Scientific TPP Development Group (Contributors: Andriansjah, et al.). (2025). **WHO target product profile for TB detection at peripheral settings: 2024 update.** *PLOS Global Public Health*, 5(6), e0004612.

## Collaborations

- **Domestic:** Eijkman Institute for Molecular Biology, Universitas Padjadjaran, RSUPN Dr. Cipto Mangunkusumo
- **International:** Leiden University Medical Center (Netherlands), Osaka University (Japan), London School of Hygiene & Tropical Medicine (UK)

## Resources & Facilities

- **Mycobacteriology Laboratory (BSL-2/BSL-3):** Facilities equipped for TB culture (LJ and MGIT), drug susceptibility testing, and safe handling of infectious mycobacteria.
- **Genomic Sequencing Unit:** Access to Next-Generation Sequencing (NGS) platforms for whole-genome sequencing and molecular surveillance.

## Contact Information

- **Office Location:** Department of Microbiology, Faculty of Medicine Universitas Indonesia, Jl. Pegangsaan Timur No. 16, Jakarta Pusat 10320
- **Office Phone:** +62 21 316 0491
- **Group Email:** mikrobiologi-fku@ui.ac.id
- **Website:** [https://research.fk.ui.ac.id/krl/kr/profil_kr/43/749/] https://research.fk.ui.ac.id/krl/kr/profil_kr/43/749